Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm
05:07

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm

Published on: August 2, 2024

1.8K

Current status of medical treatment for abdominal aortic aneurysm

Koji Kurosawa1, Jon S Matsumura, Dai Yamanouchi

  • 1Division of Vascular Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health.

Circulation Journal : Official Journal of the Japanese Circulation Society
|October 29, 2013
PubMed

Insights

Abdominal aortic aneurysm (AAA) is a significant cause of death. Medical treatments, like doxycycline which inhibits matrix metalloproteinases (MMP), aim to prevent AAA rupture and surgical intervention.

Area of Science:

  • Vascular Surgery
  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Cardiovascular disease is a leading cause of death.
  • Abdominal aortic aneurysm (AAA) ranks as the 15th leading cause of death for individuals over 65 in the USA.
  • Current standard treatments for AAA involve invasive surgical repair (open surgery or endovascular aneurysm repair).

Purpose of the Study:

  • To review the pathophysiology of AAA.
  • To explore potential medical therapies for AAA.
  • To discuss pharmacological agents that may prevent AAA rupture or enlargement.

Main Methods:

  • Review of existing literature on AAA pathophysiology.
  • Analysis of proposed pharmacological treatments for AAA.
  • Discussion of the role of matrix metalloproteinases (MMPs) in AAA development.
  • Mention of the ongoing Non-invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA(3)CT).

Main Results:

  • Matrix metalloproteinases (MMPs) are implicated in AAA pathogenesis.
  • Several drug classes, including doxycycline (an MMP inhibitor), are being investigated for medical AAA treatment.
  • Doxycycline shows promise as a potential non-invasive therapy for AAA.

Conclusions:

  • Medical management of AAA focuses on preventing rupture and avoiding surgery.
  • Doxycycline represents a promising pharmacological approach for AAA treatment.
  • Further clinical trials, such as N-TA(3)CT, are crucial to validate non-invasive AAA therapies.

More Related Videos

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation09:32

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation

Published on: September 19, 2018

17.8K
Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm04:56

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Published on: August 1, 2025

662

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
479
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
593
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
627
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
599
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
458